NVO vs INCY
Novo Nordisk A/S vs Incyte — AI-powered side-by-side comparison
| Metric | NVO | INCY |
|---|---|---|
| AI Score | 51 | 68 |
| Price | $47.08 | $119.47 |
| P/E Ratio | 11.17× | 14.70× |
| ROE | 0.5% | 0.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.9% |
| Debt / Equity | 0.72× | 0.01× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 33.8 | 49.5 |
| Beta | 0.36 | 0.758 |
| Expected Upside | +1.4% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
INCY Full Analysis